Related Experiment Video

Updated: May 22, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

ALK-mutated non-small-cell lung cancer: a new strategy for cancer treatment

Luis Cabezón-Gutiérrez1, Parham Khosravi-Shahi, Victor Manuel Diaz-Muñoz-de-la-Espada

  • 1Department of Medical Oncology, Hospital de Torrejón, 28850 Torrejón de Ardoz, Madrid, Spain. lcabezon@torrejonsalud.com

Lung
|May 16, 2012
PubMed

Insights

Anaplastic lymphoma kinase (ALK) alterations are implicated in cancer. This review covers ALK's role in lung cancer, detection methods, and clinical aspects for non-small cell lung cancer (NSCLC) patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The anaplastic lymphoma kinase (ALK) tyrosine kinase (TK) receptor is a significant target in cancer therapy.
  • Various ALK gene alterations, including mutations and translocations, contribute to tumorigenesis.

Purpose of the Study:

  • To review the role of ALK in lung tumor development.
  • To discuss methodologies for detecting molecular alterations in ALK.
  • To outline the clinical significance of ALK alterations in non-small cell lung cancer (NSCLC).

Main Methods:

  • Literature review of ALK alterations in cancer.
  • Analysis of diagnostic techniques for ALK gene rearrangements.
  • Review of clinical data on ALK-targeted therapies in NSCLC.

Main Results:

  • ALK alterations are implicated in the pathogenesis of various cancers.
  • Diverse molecular methods exist for ALK alteration detection.
  • ALK status is a critical determinant for targeted therapy selection in NSCLC.

Conclusions:

  • ALK is a relevant biomarker and therapeutic target in solid and hematologic malignancies.
  • Understanding ALK alterations is crucial for personalized lung cancer treatment.
  • Further research into ALK pathways may yield novel therapeutic strategies.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...